Rho-ROCK Inhibitors for the Treatment of CNS Injury

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|2|3|173-179

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.2, Iss.3, 2007-11, pp. : 173-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells

By  

THE PROSTATE, Vol. 73, Iss. 12, 2013-09 ,pp. : 1306-1315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Involvement of the H1 Histamine Receptor, p38 MAP Kinase, Myosin Light Chains Kinase, and Rho/ROCK in Histamine‐Induced Endothelial Barrier Dysfunction

By  

MICROCIRCULATION (ELECTRONIC), Vol. 22, Iss. 4, 2015-05 ,pp. : 237-248

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mevalonate-Ras Homology (Rho)/Rho-Associated Coiled-Coil-Forming Protein Kinase (ROCK)-Mediated Signaling Pathway as a Therapeutic Target for the Treatment of Endometriosis-Associated Fibrosis

By  

Current Signal Transduction Therapy, Vol. 5, Iss. 2, 2010-05 ,pp. : 141-148

Bentham Science Publishers

Access to resources Recommend Favorite

Estradiol attenuates the TGF-β1-induced conversion of primary TAFs into myofibroblasts and inhibits collagen production and myofibroblast contraction by modulating the Smad and Rho/ROCK signaling pathways

By            

International Journal of Molecular Medicine, Vol. 36, Iss. 3, 2015-01 ,pp. : 801-807

Spandidos Publications

Access to resources Recommend Favorite

Antiangiogenic Treatment for Multiple CNS Hemangioblastomas

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 443-445

Karger

Access to resources Recommend Favorite